erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the http://lm360.us/Carrier-brother-of-Kerfien-from-Jiangshang?Kinnearsi=96 español .
marketwatch: "new migraine drugs have promise -- and a ,500 price tag." . .